CNSX:BIO Bio-Rad Laboratories (BIO) Stock Price, News & Analysis → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free BIO Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume265,600 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Bio-Rad Laboratories alerts: Email Address Ad Stansberry ResearchWhat President Biden's new law means for investorsWhat's Got Musk, Bezos, and Gates So Excited? Billionaires are plowing millions of dollars into a new technology that early estimates say could generate more wealth than A.I. – and determine the future of companies like Microsoft. The problem? Most investors have no idea it's happening, or how to profit on it.This expert just went public with all the details, including which stocks to jump on immediately. About Bio-Rad Laboratories Stock (CNSX:BIO)Biome Grow Inc. focuses on the cannabis business. Biome Grow Inc. is headquartered in Toronto, Canada.Read More Ad Stansberry ResearchWhat President Biden's new law means for investorsWhat's Got Musk, Bezos, and Gates So Excited? Billionaires are plowing millions of dollars into a new technology that early estimates say could generate more wealth than A.I. – and determine the future of companies like Microsoft. The problem? Most investors have no idea it's happening, or how to profit on it.This expert just went public with all the details, including which stocks to jump on immediately. BIO Stock News HeadlinesMay 16, 2024 | finance.yahoo.comQ1 2024 OncoCyte Corp Earnings CallMay 10, 2024 | finance.yahoo.comHere's What Analysts Are Forecasting For Bio-Rad Laboratories, Inc. (NYSE:BIO) After Its First-Quarter ResultsMay 8, 2024 | finance.yahoo.comBio-Rad Laboratories, Inc. (NYSE:BIO) Q1 2024 Earnings Call TranscriptMay 7, 2024 | chron.comBio-Rad: Q1 Earnings SnapshotMay 7, 2024 | msn.comBio-Rad Labs Non-GAAP EPS of $2.29 beats by $0.15, revenue of $610.8M misses by $9.31MMay 7, 2024 | finance.yahoo.comBio-Rad Laboratories Inc (BIO) Q1 2024 Earnings: Mixed Results Amid Market ChallengesMay 6, 2024 | markets.businessinsider.comHere's what to expect from Bio-Rad Laboratories B's earningsMay 6, 2024 | markets.businessinsider.comBio-Rad Laboratories earnings: here's what Wall Street expectsApril 17, 2024 | finance.yahoo.comBio-Rad Laboratories (NYSE:BIO shareholders incur further losses as stock declines 14% this week, taking three-year losses to 53%April 14, 2024 | seekingalpha.comBio-Rad: A Lackluster Picks-And-Shovels Life Science Company With A Key Investment KickerApril 13, 2024 | finance.yahoo.comOncoCyte Corp (OCX) Q4 2023 Earnings Call Transcript Highlights: Strategic Partnerships and ...April 9, 2024 | markets.businessinsider.comRBC Capital Reaffirms Their Buy Rating on Bio-Rad Laboratories (BIO)March 25, 2024 | uk.finance.yahoo.comGlobal Blood Glucose Monitoring System Market Poised for Substantial Growth by 2030March 20, 2024 | markets.businessinsider.comBio-Rad Laboratories Appoints Roop Lakkaraju As EVP And CFOMarch 20, 2024 | businesswire.comBio-Rad Appoints Roop K. Lakkaraju Executive Vice President, Chief Financial OfficerMarch 18, 2024 | finanznachrichten.deContinuous Bioprocessing Market Worth $1,067.8 Mn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.March 16, 2024 | finance.yahoo.comBIO Apr 2024 420.000 callMarch 16, 2024 | finance.yahoo.comBIO Apr 2024 185.000 putMarch 13, 2024 | theglobeandmail.comBlood Group Typing Market worth $3.0 billion by 2028 | MarketsandMarketsFebruary 22, 2024 | finance.yahoo.comBio-Rad to Participate in Fireside Chat During Citi's 2024 Unplugged Medtech and Life Sciences Access DayFebruary 21, 2024 | finance.yahoo.comBIO Jun 2024 270.000 putFebruary 16, 2024 | msn.comREFILE-Bio Rad Labs rises after posting upbeat fourth-quarter profitFebruary 16, 2024 | finance.yahoo.comBio-Rad (BIO) Q4 Earnings Beat, Revenues Miss, Margins DownFebruary 16, 2024 | finance.yahoo.comBio-Rad Laboratories, Inc. (NYSE:BIO) Q4 2023 Earnings Call TranscriptFebruary 16, 2024 | finance.yahoo.comQ4 2023 Bio Rad Laboratories Inc Earnings CallSee More Headlines Receive BIO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Bio-Rad Laboratories and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCNSX SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolCNSX:BIO CUSIPN/A CIKN/A Webwww.biomegrow.com Phone416-875-8395FaxN/AEmployees8,000Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Key ExecutivesMr. Khurram Malik MBACEO, President & DirectorMr. Abbey Abdiye C.M.A. (Age 49)CPA, Chief Financial Officer Comp: $110.95kScott CuthbertsonVP of Investor RelationsMr. Frank MacMasterPresident of Highland Grow Inc.David CallahanPresident of The Back Home Medical Cannabis CorporationKey CompetitorsAbattis BioceuticalsCNSX:ATTAgraflora Organics InternationalCNSX:AGRAAmplify Alternative Harvest ETFCNSX:MJBlueberries MedicalCNSX:BBMBooksAMillionCNSX:BAMMView All Competitors BIO Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Bio-Rad Laboratories own? Based on aggregate information from My MarketBeat watchlists, some companies that other Bio-Rad Laboratories investors own include Cross Timbers Royalty Trust (CRT), InfraCap MLP ETF (AMZA), Alliance Resource Partners (ARLP), Curaleaf (CURLF), Cannara Biotech (LOVE), Brigham Minerals (MNRL) and Arbor Realty Trust (ABR). How do I buy shares of Bio-Rad Laboratories? Shares of BIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (CNSX:BIO) was last updated on 5/21/2024 by MarketBeat.com Staff From Our PartnersProtect Your Bank Account Before It’s Too LateWeiss RatingsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersBuy this small stock before coming AI Tidal WaveChaikin AnalyticsThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarWarren Buffett's "mystery stock"Stansberry ResearchThis Could be Your “Big Money” AI MomentInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bio-Rad Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.